NFKB1 and type 2 diabetes mellitus: These findings indicate that CS/Res/Se-NPs, particularly at the higher dose (CS/Res/Se-NPs-10), effectively reduced the expression of NF-κB and iNOS in the liver tissues of T2D mice.